Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index N

Nadolol
in abnormal heart rhythms: Sec. 3, Ch. 47
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Napping: Sec. 3 Ch. 31 [sidebar]
Naproxen
for pain: Sec. 3, Ch. 24
in rheumatoid arthritis: Sec. 3, Ch. 41
Narcolepsy: Sec. 3, Ch. 31
Nasal spray
in allergic rhinitis: Sec. 3, Ch. 38
in vasomotor rhinitis: Sec. 3, Ch. 38
in viral rhinitis: Sec. 3, Ch. 38
in viral sinusitis: Sec. 3, Ch. 38
Nasopharynx: Sec. 3, Ch. 38
Nateglinide: Sec. 3, Ch. 34
National Center on Elder Abuse: Sec. 4, Ch. 64
National organizations for health information: 881-889
Nausea
in cancer: Sec. 3, Ch. 50; Sec. 3, Ch. 50
in terminal illness: Sec. 2, Ch. 16
Nebulizer: Sec. 3, Ch. 53
Neck
cancer of: Sec. 3, Ch. 51
spasms of: Sec. 3, Ch. 30
Needle biopsy: (see Biopsy)
Nefazodone
in depression: Sec. 3, Ch. 32
in insomnia: Sec. 3, Ch. 31
Neglect: Sec. 4, Ch. 64; Sec. 4 Ch. 64 [sidebar]
Neoplasm: Sec. 3, Ch. 50 (see also Cancer)
Nephrologist: Sec. 2, Ch. 9
Nerve block
in trigeminal neuralgia: Sec. 3, Ch. 29
Nerve cells
in brain: Sec. 1, Ch. 2
Nerve conduction velocity: Sec. 2, Ch. 10; Sec. 3, Ch. 29
Nerve(s)
aging of: Sec. 1, Ch. 2
amyloid deposition in: Sec. 3 Ch. 29 [sidebar]
disorders of: Sec. 3, Ch. 29 (see also Neuropathy)
     in vitamin B12 deficiency: Sec. 3, Ch. 49
tests of: Sec. 2, Ch. 10
Nervous system
aging of: Sec. 1, Ch. 2
Nervousness: (see Anxiety)
Nesiritide: Sec. 3, Ch. 46
Neuralgia: Sec. 3, Ch. 29
postherpetic: Sec. 3, Ch. 24; Sec. 3, Ch. 35
trigeminal: Sec. 3, Ch. 29
Neurofibrillary tangles: Sec. 3, Ch. 27
Neurogenic bladder: Sec. 3, Ch. 56
Neurologist: Sec. 2, Ch. 9
Neuropathy: Sec. 3, Ch. 29; Sec. 3, Ch. 29
amyloid: Sec. 3 Ch. 29 [sidebar]
in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34; Sec. 3 Ch. 34 [sidebar]
optic: Sec. 3, Ch. 36
in vitamin B12 deficiency: Sec. 3, Ch. 49
Neurotransmitters: Sec. 1, Ch. 2
in Alzheimer's disease: Sec. 3, Ch. 27
in delirium: Sec. 3 Ch. 26 [detail]
in dementia: Sec. 3, Ch. 27
Niacin: Sec. 3, Ch. 44
Nicardipine
in coronary artery disease: Sec. 3, Ch. 45
in high blood pressure: Sec. 3, Ch. 43
Nifedipine: Sec. 3, Ch. 45
Night driving: Sec. 4, Ch. 62
Night terrors: Sec. 3, Ch. 31
Nilutamide: Sec. 3, Ch. 51
Nisoldipine
in coronary artery disease: Sec. 3, Ch. 45
in high blood pressure: Sec. 3, Ch. 43
Nitrates
in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45
dizziness with: Sec. 3, Ch. 20
after heart attack: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46
Nizatidine: Sec. 2, Ch. 6
Nociceptive pain: Sec. 3 Ch. 24 [detail]
Nocturia
in benign prostatic hyperplasia: Sec. 3, Ch. 59
diuretics and: Sec. 3, Ch. 18
infection and: Sec. 3, Ch. 56
sleep disturbance with: Sec. 3, Ch. 31
Nodules
thyroid: Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33
Noise
hearing and: Sec. 1, Ch. 2; Sec. 1, Ch. 2; Sec. 3, Ch. 37
measurement of: Sec. 3 Ch. 37 [sidebar]
protection from: Sec. 3 Ch. 37 [sidebar]
Nonketotic (hyperglycemic) hyperosmolar coma: Sec. 3, Ch. 34
Nonsteroidal anti-inflammatory drugs (NSAIDs)
alcohol interactions with: Sec. 3 Ch. 32 [sidebar]
discontinuation of
     before colonoscopy: Sec. 2, Ch. 10
     before electromyography: Sec. 2, Ch. 10
     before esophagogastroduodenoscopy: Sec. 2, Ch. 10
     before prostatic biopsy: Sec. 2, Ch. 10
     before skin biopsy: Sec. 2, Ch. 10
esophageal damage with: Sec. 3, Ch. 54
in gout: Sec. 3, Ch. 41; Sec. 3, Ch. 41
in heart failure: Sec. 3, Ch. 46
in osteoarthritis: Sec. 3, Ch. 41
overhydration with: Sec. 3, Ch. 18; Sec. 3, Ch. 18
for pain: Sec. 3, Ch. 24
platelet function and: Sec. 3, Ch. 49
in pseudogout: Sec. 3, Ch. 41
in rheumatoid arthritis: Sec. 3, Ch. 41; Sec. 3, Ch. 41
Normal-pressure hydrocephalus: Sec. 3 Ch. 27 [sidebar]
Nortriptyline
in depression: Sec. 3, Ch. 32
urinary incontinence with: Sec. 3, Ch. 57
Nose: Sec. 3, Ch. 38
aging-related changes in: Sec. 1, Ch. 2
enlargement of (rhinophyma): Sec. 3, Ch. 35
inflammation of (rhinitis): Sec. 3, Ch. 38
irrigation of: Sec. 3, Ch. 38
NREM (nonrapid eye movement) sleep: Sec. 3 Ch. 31 [detail]
NSAIDs: (see Nonsteroidal anti-inflammatory drugs [NSAIDs])
Nuclear scan: Sec. 3, Ch. 45
Nurse practitioner: Sec. 2, Ch. 9
Nurse
for home health care: Sec. 2, Ch. 9
for senior center: Sec. 2, Ch. 9
Nurses' aide: Sec. 2, Ch. 9; Sec. 2, Ch. 9
Nursing homes: Sec. 2, Ch. 9; Sec. 2, Ch. 14; Sec. 2, Ch. 14
in dementia: Sec. 3, Ch. 27
demographics of: Sec. 1, Ch. 3
eating in: Sec. 2 Ch. 14 [sidebar]; Sec. 3 Ch. 17 [sidebar]
evaluations of: Sec. 2, Ch. 14
influenza vaccine in: Sec. 3, Ch. 52
intimacy needs and: Sec. 4, Ch. 63
overnight care in: Sec. 2, Ch. 15
payment for: Sec. 2, Ch. 14
pneumonia in: Sec. 3, Ch. 52; Sec. 3, Ch. 52
regulation of: Sec. 2, Ch. 14
Nursing units: Sec. 2, Ch. 11
Nutraceutical: Sec. 2, Ch. 7 (see also Dietary supplements)
Nutrition: Sec. 2, Ch. 5 (see also Diet; Food)
disorders of: Sec. 3, Ch. 17
during hospitalization: Sec. 2, Ch. 11
for dying person: Sec. 2, Ch. 16
food labels for: Sec. 2, Ch. 5
for healthy diet: Sec. 2, Ch. 4; Sec. 3, Ch. 17
information resources on: 888
in pressure sore prevention: Sec. 3, Ch. 35
screening for: Sec. 2, Ch. 5
supplements for: Sec. 3, Ch. 17
after surgery: Sec. 2, Ch. 12
Nystagmus: Sec. 3, Ch. 20
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.